Drug interactions
Apalutamide + Brentuximab vedotin
Severity: Moderate
Apalutamide and Brentuximab vedotin: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
The MMAE payload of brentuximab vedotin is a CYP3A4 substrate, and apalutamide induces CYP3A4. Free MMAE exposure may decline, though the clinical impact is not well characterized.
What this interaction means in plain words
Apalutamide and Brentuximab vedotin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Apalutamide belongs to Endocrine; Brentuximab vedotin belongs to Oncology.
Why it happens
Apalutamide induces CYP3A4, which may increase metabolism of released MMAE.
What to do
Monitor for reduced treatment response. Consider an alternative to apalutamide if feasible.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Apalutamide and Brentuximab vedotin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Apalutamide
- Apalutamide + Cabotegravir Contraindicated
- Apalutamide + Cobicistat Contraindicated
- Apalutamide + Doravirine Contraindicated
- Apalutamide + Elbasvir / grazoprevir Contraindicated
- Apalutamide + Ensitrelvir Contraindicated
- Apalutamide + Fostemsavir Contraindicated
Other interactions of Brentuximab vedotin
- Bleomycin + Brentuximab vedotin Contraindicated
- Brentuximab vedotin + Siponimod Major
- Brentuximab vedotin + Clarithromycin Moderate
- Brentuximab vedotin + Imatinib Moderate
- Brentuximab vedotin + Isoniazid Moderate
- Brentuximab vedotin + Itraconazole Moderate
Frequently asked questions
Can I take Apalutamide with Brentuximab vedotin?
MediHelp rates the interaction as moderate. Apalutamide and Brentuximab vedotin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. The MMAE payload of brentuximab vedotin is a CYP3A4 substrate, and apalutamide induces CYP3A4. Free MMAE exposure may decline, though the clinical impact is not well characterized.
How serious is the interaction between Apalutamide and Brentuximab vedotin?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for reduced treatment response. Consider an alternative to apalutamide if feasible.
What other medicines interact with Apalutamide?
MediHelp also lists interactions of Apalutamide with, for example, Cabotegravir, Cobicistat, Doravirine. The full list is on the Apalutamide page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
